Invesco Ltd [NYSE: IVZ] gained 1.45% or 0.22 points to close at $15.36 with a heavy trading volume of 2900068 shares.
The daily chart for IVZ points out that the company has recorded 11.55% gains over the past six months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If we look at the average trading volume of 4.32M shares, IVZ reached to a volume of 2900068 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Invesco Ltd [IVZ]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IVZ shares is $16.62 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IVZ stock is a recommendation set at 2.76. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
TD Cowen have made an estimate for Invesco Ltd shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on January 04, 2024. While these analysts kept the previous recommendation, Keefe Bruyette raised their target price from $15.50 to $20. The new note on the price target was released on December 14, 2023, representing the official price target for Invesco Ltd stock. Previously, the target price had yet another raise from $15 to $21, while BMO Capital Markets kept a Market Perform rating on IVZ stock.
The Average True Range (ATR) for Invesco Ltd is set at 0.35, with the Price to Sales ratio for IVZ stock in the period of the last 12 months amounting to 1.20. The Price to Book ratio for the last quarter was 0.66, with the Price to Cash per share for the same quarter was set at 3.17. Price to Free Cash Flow for IVZ in the course of the last twelve months was 5.64.
Trading performance analysis for IVZ stock
Invesco Ltd [IVZ] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.72. With this latest performance, IVZ shares gained by 8.40% in over the last four-week period, additionally plugging by 11.55% over the last 6 months – not to mention a rise of 3.64% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IVZ stock in for the last two-week period is set at 47.46, with the RSI for the last a single of trading hit 45.18, and the three-weeks RSI is set at 48.12 for Invesco Ltd [IVZ]. The present Moving Average for the last 50 days of trading for this stock 15.59, while it was recorded at 15.41 for the last single week of trading, and 15.31 for the last 200 days.
Invesco Ltd [IVZ]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for IVZ. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Invesco Ltd go to 10.35%.
An analysis of Institutional ownership at Invesco Ltd [IVZ]
The top three institutional holders of IVZ stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in IVZ stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in IVZ stock with ownership which is approximately 5.8386%.